{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:09Z","timestamp":1760854029439},"publisher-location":"New York, NY","reference-count":32,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493978465"},{"type":"electronic","value":"9781493978472"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7847-2_3","type":"book-chapter","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T17:26:51Z","timestamp":1525714011000},"page":"41-52","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages"],"prefix":"10.1007","author":[{"given":"Nobutaka","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"March","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta N.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"3_CR1","unstructured":"World Health Organization WHO (2016) World Malaria Report"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature19804","volume":"538","author":"N Kato","year":"2016","unstructured":"Kato N, Comer E, Sakata-Kato T et al (2016) Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 538:344\u2013349","journal-title":"Nature"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery EL, Chatterjee AK, Winzeler EA (2013) Antimalarial drug discovery\u2014approaches and progress towards new medicines. Nat Rev Microbiol 11:849\u2013862","journal-title":"Nat Rev Microbiol"},{"key":"3_CR4","first-page":"279","volume":"36","author":"v JF Eichborn","year":"1986","unstructured":"Eichborn v JF (1986) Medical and commercial aspects of human interferon. Arzneimittelforschung 36:279\u2013282","journal-title":"Arzneimittelforschung"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1128\/AAC.01144-06","volume":"51","author":"ML Baniecki","year":"2007","unstructured":"Baniecki ML, Wirth DF, Clardy J (2007) High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother 51:716\u2013723","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","volume":"48","author":"TN Bennett","year":"2004","unstructured":"Bennett TN, Paguio M, Gligorijevic B et al (2004) Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother 48:1807\u20131810","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX et al (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803\u20131806","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ (2011) Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 10:297","journal-title":"Malar J"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2960","volume":"8","author":"D Mazier","year":"2009","unstructured":"Mazier D, R\u00e9nia L, Snounou G (2009) A pre-emptive strike against malaria\u2019s stealthy hepatic forms. Nat Rev Drug Discov 8:854\u2013864","journal-title":"Nat Rev Drug Discov"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4269\/ajtmh.1982.31.1291","volume":"31","author":"WA Krotoski","year":"1982","unstructured":"Krotoski WA, Collins WE, Bray RS et al (1982) Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg 31:1291\u20131293","journal-title":"Am J Trop Med Hyg"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","volume":"14","author":"S March","year":"2013","unstructured":"March S, Ng S, Velmurugan S et al (2013) A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14:104\u2013115","journal-title":"Cell Host Microbe"},{"key":"3_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014275","volume":"5","author":"R Chattopadhyay","year":"2010","unstructured":"Chattopadhyay R, Velmurugan S, Chakiath C et al (2010) Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS One 5:e14275","journal-title":"PLoS One"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein JE, Tewari K, Lyke KE et al (2011) Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334:475\u2013480","journal-title":"Science"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","volume":"334","author":"S Meister","year":"2011","unstructured":"Meister S, Plouffe DM, Kuhen KL et al (2011) Imaging of plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334:1372\u20131377","journal-title":"Science"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/infdis\/jis184","volume":"205","author":"FP Cruz da","year":"2012","unstructured":"da Cruz FP, Martin C, Buchholz K et al (2012) Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug. J Infect Dis 205:1278\u20131286","journal-title":"J Infect Dis"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4269\/ajtmh.2006.74.708","volume":"74","author":"J Sattabongkot","year":"2006","unstructured":"Sattabongkot J, Yimamnuaychoke N, Leelaudomlipi S et al (2006) Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg 74:708\u2013715","journal-title":"Am J Trop Med Hyg"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1126\/science.3880923","volume":"227","author":"D Mazier","year":"1985","unstructured":"Mazier D, Beaudoin RL, Mellouk S et al (1985) Complete development of hepatic stages of Plasmodium falciparum in vitro. Science 227:440\u2013442","journal-title":"Science"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/307367a0","volume":"307","author":"D Mazier","year":"1984","unstructured":"Mazier D, Landau I, Druilhe P et al (1984) Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature 307:367\u2013369","journal-title":"Nature"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1096\/fasebj.13.14.1883","volume":"13","author":"SN Bhatia","year":"1999","unstructured":"Bhatia SN, Balis UJ, Yarmush ML, Toner M (1999) Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 13:1883\u20131900","journal-title":"FASEB J"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nbt1361","volume":"26","author":"SR Khetani","year":"2008","unstructured":"Khetani SR, Bhatia SN (2008) Microscale culture of human liver cells for drug development. Nat Biotechnol 26:120\u2013126","journal-title":"Nat Biotechnol"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/nprot.2015.128","volume":"10","author":"S March","year":"2015","unstructured":"March S, Ramanan V, Trehan K et al (2015) Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat Protoc 10:2027\u20132053","journal-title":"Nat Protoc"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nm.3461","volume":"20","author":"L Dembele","year":"2014","unstructured":"Dembele L, Franetich J-F, Lorthiois A et al (2014) Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nat Med 20:307\u2013312","journal-title":"Nat Med"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/nprot.2007.257","volume":"2","author":"S Thiberge","year":"2007","unstructured":"Thiberge S, Blazquez S, Baldacci P et al (2007) In vivo imaging of malaria parasites in the murine liver. Nat Protoc 2:1811\u20131818","journal-title":"Nat Protoc"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1073\/pnas.1118370109","volume":"109","author":"ER Derbyshire","year":"2012","unstructured":"Derbyshire ER, Prud\u00eancio M, Mota MM, Clardy J (2012) Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proc Natl Acad Sci U S A 109:8511\u20138516","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acsinfecdis.5b00143","volume":"2","author":"J Swann","year":"2016","unstructured":"Swann J, Corey V, Scherer CA et al (2016) High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria. ACS Infect Dis 2:281\u2013293","journal-title":"ACS Infect Dis"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nprot.2015.072","volume":"10","author":"NMB Brancucci","year":"2015","unstructured":"Brancucci NMB, Goldowitz I, Buchholz K et al (2015) An assay to probe Plasmodium falciparum growth, transmission stage formation and early gametocyte development. Nat Protoc 10:1131\u20131142","journal-title":"Nat Protoc"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","volume":"105","author":"D Plouffe","year":"2008","unstructured":"Plouffe D, Brinker A, McNamara C et al (2008) From the Cover: in silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A 105:9059\u20139064","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.drudis.2015.06.009","volume":"20","author":"TT Diagana","year":"2015","unstructured":"Diagana TT (2015) Supporting malaria elimination with 21st century antimalarial agent drug discovery. Drug Discov Today 20:1265\u20131270","journal-title":"Drug Discov Today"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"F-J Gamo","year":"2010","unstructured":"Gamo F-J, Sanz LM, Vidal J et al (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305\u2013310","journal-title":"Nature"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.molbiopara.2012.10.004","volume":"186","author":"AM Vaughan","year":"2012","unstructured":"Vaughan AM, Mikolajczak SA, Camargo N et al (2012) A transgenic Plasmodium falciparum NF54 strain that expresses GFP\u2013luciferase throughout the parasite life cycle. Mol Biochem Parasitol 186:143\u2013147","journal-title":"Mol Biochem Parasitol"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","volume":"17","author":"SA Mikolajczak","year":"2015","unstructured":"Mikolajczak SA, Vaughan AM, Kangwanrangsan N et al (2015) Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17:526\u2013535","journal-title":"Cell Host Microbe"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4269\/ajtmh.2012.11-0264","volume":"86","author":"WE Collins","year":"2012","unstructured":"Collins WE, Sullivan JS, Jeffery GM et al (2012) Mosquito infection studies with Aotus monkeys and humans infected with the Chesson strain of Plasmodiun vivax. Am J Trop Med Hyg 86:398\u2013402","journal-title":"Am J Trop Med Hyg"}],"container-title":["Methods in Molecular Biology","Phenotypic Screening"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7847-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T17:24:58Z","timestamp":1571333098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7847-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978465","9781493978472"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7847-2_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}